Arch Biopartners Inc. will be featured in the 2026 American Diabetes Association Thought Leadership Series during the ADA's 86th Scientific Sessions in New Orleans, highlighting their pioneering work on diabetic kidney disease (DKD) therapies. Their film showcases new biology research, including findings on IL-32 linked to kidney injury, and promotes their drug development programs targeting acute and chronic kidney diseases. This exposure increases visibility for Arch's innovative treatments addressing kidney damage affecting over 800 million people worldwide. The film and series will be available online for broader access beyond the conference.
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
